BrainStorm Cell Therapeutics
BCLI
#10103
Rank
A$11.35 M
Marketcap
$1.74
Share price
14.87%
Change (1 day)
-85.94%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of December 2024 : A$0.29 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has A$0.29 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$4.38 M-85.62%
2021-12-31A$30.47 M-44.12%
2020-12-31A$54.53 M6610.78%
2019-12-31A$0.81 M-91.9%
2018-12-31A$10.02 M0.93%
2017-12-31A$9.93 M-28.32%
2016-12-31A$13.85 M-36.72%
2015-12-31A$21.9 M109.86%
2014-12-31A$10.43 M165.74%
2013-12-31A$3.92 M-0.12%
2012-12-31A$3.93 M109.65%
2011-12-31A$1.87 M1948.44%
2010-12-31A$0.09 M8124.55%
2009-12-31A$0 M-60.73%
2008-12-31A$0 M-97.12%
2007-12-31A$0.09 M29.24%
2006-12-31A$0.07 M
2006-03-31A$0.41 M-39.65%
2005-03-31A$0.68 M11050.5%
2004-03-31A$0 M-63.12%
2003-03-31A$0.01 M-75.54%
2002-03-31A$0.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$17.98 B 6,185,996.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.67 B 575,306.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.92 B 661,391.98%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.69 B 1,269,953.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$62.85 M 21,524.06%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA